# Joe Rokicki

> Joe Rokicki is an engineer-turned-molecular biologist and Founding Fellow at Enveda in Boulder. A Princeton electrical engineering graduate with a PhD in molecular, cellular and developmental biology from the University of Colorado Boulder, he has moved through bacterial genomics, synthetic biology, DNA sequencing and targeted protein degradation. As Enveda's founding CTO, he led early zero-to-one technical work behind a platform that combines metabolomics, machine learning and laboratory automation to search nature's chemistry for potential medicines.

- **Role:** Founding Fellow at Enveda
- **Organizations:** Enveda, Plexium, Omniome, University of Colorado Boulder, Princeton University
- **Education:** B.S.E. in Electrical Engineering; Certificate in Quantitative and Computational Biology, Princeton University, PhD in Molecular, Cellular and Developmental Biology, University of Colorado Boulder
- **Known for:** Co-founded Plexium, a biotechnology company focused on targeted protein degradation., Served as Enveda's founding Chief Technology Officer and established a Research Accelerator for zero-to-one technical work., Co-created CodaChrome, an interactive tool for comparing a bacterial proteome against thousands of sequenced genomes.

## Career timeline

- **2004** — Entered Princeton University and joined its integrated science sequence, combining engineering, computer science, biology and physics.
- **2007** — Participated in the University of Edinburgh iGEM team, whose projects included an attempt at self-flavouring yogurt.
- **2008** — Completed a B.S.E. in Electrical Engineering at Princeton, with a certificate in Quantitative and Computational Biology.
- **2009-2015** — Completed doctoral training in molecular, cellular and developmental biology at the University of Colorado Boulder, working on bacterial evolution and enzymology.
- **2012** — Co-led the first CU Boulder iGEM team, which attempted to engineer a bacterial night-light.
- **2014** — Co-authored CodaChrome, an interactive bacterial proteome comparison tool, and published the hands-on protocol Beer Bottle Minipreps.
- **2015-2017** — Worked at next-generation sequencing company Omniome across molecular biology, robotics, programming and instrument engineering.
- **2017** — Co-founded Plexium, a targeted protein degradation company.
- **2019** — Joined Enveda as founding Chief Technology Officer and later ran its Research Accelerator for zero-to-one technical projects.
- **2022** — Co-authored research on causal reasoning over knowledge graphs for drug discovery.
- **Current** — Serves as Founding Fellow at Enveda; the company's current leadership page lists August Allen as Chief Technology Officer.

## Achievements

- Co-founded Plexium, a biotechnology company focused on targeted protein degradation.
- Served as Enveda's founding Chief Technology Officer and established a Research Accelerator for zero-to-one technical work.
- Co-created CodaChrome, an interactive tool for comparing a bacterial proteome against thousands of sequenced genomes.
- Co-led the first University of Colorado Boulder iGEM team and helped establish the university's synthetic biology program.
- Is named as an inventor on multiple granted patents covering DNA sequencing workflows and oligonucleotide-encoded chemical libraries.
- Co-authored peer-reviewed work applying causal reasoning over knowledge graphs to drug discovery.

## Latest updates

- **2026-09** — Public organizational listings identify Rokicki as Founding Fellow at Enveda, while Enveda's leadership page names August Allen as Chief Technology Officer.
- **2026-05** — A US patent for oligonucleotide-encoded chemical libraries naming Joseph Franklin Rokicki as an inventor was issued.
- **2025-07** — A US patent for cognate-nucleotide detection in sequencing workflows naming Rokicki as an inventor was issued.

## Links

- Website: https://enveda.com
- LinkedIn: https://www.linkedin.com/in/joe-rokicki-31306598

---

Profile page: https://yespress.io/joe-rokicki
Published by YesPress — https://yespress.io
Last updated: 2026-09-27